Position in ABBV
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$4,059,708
+$476,126 QoQ
Shares Held
16,133
-2.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#1,447
of 4,153 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Focus Financial Network, Inc. holds $24,753,485 across 11 Drug Manufacturers - General names. ABBV ranks #3 (16.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,014 | $8,412,802 | |
| 2 | JNJ |
Johnson & Johnson
|
26,353 | $6,692,871 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
16,133 | $4,059,708 | |
| 4 | MRK |
Merck & Co., Inc.
|
10,855 | $1,394,867 | |
| 5 | AMGN |
Amgen Inc
|
3,743 | $1,355,415 | |
| 6 | PFE |
Pfizer Inc
|
44,319 | $1,067,201 | |
| 7 | NVO |
Novo Nordisk A S
|
17,017 | $815,794 | |
| 8 | NVS |
Novartis AG
|
2,032 | $318,455 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,059,708 | 16,133 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $3,583,582 | 16,477 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $3,948,535 | 17,281 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $3,959,565 | 17,101 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $3,053,634 | 16,451 | Shares | Sole | 2025-07-10 | |
| 2025-03-31 | $3,363,843 | 16,055 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $2,857,416 | 16,080 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $3,511,589 | 17,782 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $2,994,224 | 17,457 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $2,934,177 | 16,113 | Shares | Sole | 2024-04-24 | |
| 2023-09-30 | $2,215,925 | 14,866 | Shares | Sole | 2024-07-23 | |
| 2023-06-30 | $2,165,919 | 16,076 | Shares | Sole | 2024-07-23 | |
| 2023-03-31 | $2,615,421 | 16,411 | Shares | Sole | 2024-07-23 | |
| 2022-12-31 | $2,775,328 | 17,173 | Shares | Sole | 2024-07-24 | |
| 2022-09-30 | $2,294,051 | 17,093 | Shares | Sole | 2024-07-24 | |
| 2022-06-30 | $2,614,288 | 17,069 | Shares | Sole | 2024-07-24 | |
| 2022-03-31 | $2,718,584 | 16,770 | Shares | Sole | 2024-07-24 | |
| 2021-12-31 | $6,887,391 | 50,867 | Shares | Sole | 2024-07-24 | |
| 2021-09-30 | $5,186,821 | 48,084 | Shares | Sole | 2024-07-24 | |
| 2021-06-30 | $5,138,298 | 45,617 | Shares | Sole | 2024-07-24 | |
| 2021-03-31 | $6,475,235 | 59,834 | Shares | Sole | 2024-07-24 | |
| 2020-12-31 | $1,694,470 | 15,814 | Shares | Sole | 2024-07-24 | |
| 2020-09-30 | $1,267,514 | 14,471 | Shares | Sole | 2024-07-24 | |
| 2020-06-30 | $1,368,334 | 13,937 | Shares | Sole | 2024-07-24 | |
| 2020-03-31 | $633,596 | 8,316 | Shares | Sole | 2024-07-24 | |
| No filing history on record for this holder in this stock. | ||||||